Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Has results
×
Parkinson Disease 4, Autosomal Dominant Lewy Body
×
Doxorubicin
×
Clear all
Filters
3
NCT03517449
2025-06-15
MK-3475-775
Eisai Inc.
Phase 3
Completed
827 enrolled
18 charts
1 FDA
NCT02622074
2020-09-10
KEYNOTE 173
Merck Sharp & Dohme LLC
Phase 1
Completed
60 enrolled
26 charts